
265.97MUSD

See which Billionaires own this investment
Type
Common Stock
Exchange
NASDAQ
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
US0144421072
CUSIP
014442107
Sector
Healthcare
Industry
Biotechnology
Fiscal Year End
December
IPO date
-
Updated At
-
PE Ratio
-
PEG Ratio
-
Book Value
0.28
Dividend Share
-
Dividend Yield
-
Earnings Share
-1.39
Wall Street Target Price
2.88
EPS Estimate Current Year
-0.85
EPS Estimate Next Year
-0.88
EPS Estimate Current Quarter
-0.3633
EPS Estimate Next Quarter
-0.23
Most Recent Quarter
-
Revenue TTM
21,045,000
Gross Profit TTM
-102,020,000
EBITDA
-147,367,008
Profit Margin
0.00%
Return On Assets TTM
-25.13%
Return On Equity TTM
-181.56%
Revenue Per Share TTM
0.204
Qtly Revenue Growth YOY
-88.50%
Diluted Eps TTM
-1.39
Qtly Earnings Growth YOY
-86.30%
Trailing PE
0.00
Forward PE
8
Price Sales TTM
12.2975
Price Book MRQ
8.6781
Enterprise Value Revenue
2
Enterprise Value EBITDA
-8
99.19
3.80%777.07
3.74%316.64
3.69%330.43
3.65%24.37
0.70%154.00
0.60%303.50
0.34%434.64
0.08%712.02
0.00%755.43
-1.02%